cell-based assays
Biocept Licenses CNSide Liquid Biopsy Assay to Plus Therapeutics
Under the agreement, Plus is using the cerebrospinal fluid cell-based assay in its ongoing clinical trial of the radiotherapeutic rhenium 186 obisbemeda.
Cell Microsystems Acquires Fluxion Biosciences; Announces Series B Financing
The Durham, North Carolina-based cell biology tech firm said the acquisition was supported by a concurrent Series B financing led by Telegraph Hill Partners.
While Samplix initially launched with a platform for DNA target enrichment, it has decided to refocus on applying its microfluidics technology in the cell screening market.
Bio-Techne to Acquire Single-Cell Sorting Firm Namocell
Namocell offers Pala, a two-laser system with up to 11 fluorescent detection channels, and Hana, a single-laser system with two fluorescent detection channels.
CareDx Receives CE Mark for Hematopoietic Cell Transplantation Testing Kit, Analysis Software
The designation furthers the firm's expansion into the stem cell transplant space, which began with the launch of AlloCell in 2020.